Dennis Schade
Impact in
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology
-
- Pluripotent Stem Cells Research
- Congenital heart defects research
- Chemical Synthesis and Analysis
- Cancer-related gene regulation
- CRISPR and Genetic Engineering
Papers in
-
- TGF-β signaling in diseases 7
- Pluripotent Stem Cells Research 7
- Cancer-related gene regulation 7
- Congenital heart defects research 5
- CRISPR and Genetic Engineering 5
- Physiology 10
- Nitric Oxide and Endothelin Effects 10
- Co-authors
- Bernd Clement (19 shared papers)Joscha Kotthaus (9 shared papers)Erik Willems (6 shared papers)Mark Mercola (4 shared papers)Marion Lanier (3 shared papers)John R. Cashman (3 shared papers)Paul Bushway (2 shared papers)Walter Raasch (3 shared papers)
- Journals
- Journal of Medicinal Chemistry (11 papers)ChemMedChem (5 papers)Bioorganic & Medicinal Chemistry (4 papers)ACS Pharmacology & Translational Science (3 papers)Cell stem cell (2 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Dennis Schade
46 papers receiving 990 citations
Peers
Comparison fields: 5 of 89
- Biochemistry 75
- Molecular Biology 572
- Organic Chemistry 235
- Physiology 110
- Oncology 112
Countries citing papers authored by Dennis Schade
This map shows the geographic impact of Dennis Schade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis Schade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis Schade more than expected).
Fields of papers citing papers by Dennis Schade
This network shows the impact of papers produced by Dennis Schade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis Schade. The network helps show where Dennis Schade may publish in the future.
Co-authors
The 25 scholars most cited alongside Dennis Schade, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 113 | |
| 2 | 2017 | 91 | |
| 3 | 2015 | 80 | |
| 4 | 2014 | 79 | |
| 5 | 2010 | 78 | |
| 6 | 2012 | 62 | |
| 7 | 2011 | 55 | |
| 8 | 2018 | 48 | |
| 9 | 2010 | 34 | |
| 10 | 2013 | 32 | |
| 11 | 2008 | 29 | |
| 12 | 2008 | 22 | |
| 13 | 2011 | 21 | |
| 14 | 2015 | 19 | |
| 15 | 2019 | 18 | |
| 16 | 2015 | 17 | |
| 17 | 2020 | 16 | |
| 18 | 2011 | 16 | |
| 19 | 2019 | 16 | |
| 20 | 2018 | 14 |
About Dennis Schade
Dennis Schade is a scholar working on Molecular Biology, Physiology, Organic Chemistry, Oncology and Biochemistry, having authored 49 papers that have together received 1.0k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (10 papers), TGF-β signaling in diseases (7 papers), Pluripotent Stem Cells Research (7 papers), Cancer-related gene regulation (7 papers), Congenital heart defects research (5 papers), Eicosanoids and Hypertension Pharmacology (5 papers), CRISPR and Genetic Engineering (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Biochemistry (75 citations), Molecular Biology (572 citations), Organic Chemistry (235 citations), Physiology (110 citations) and Oncology (112 citations). Dennis Schade has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Bernd Clement, Joscha Kotthaus, Erik Willems, Mark Mercola, Marion Lanier, John R. Cashman, Paul Bushway, Walter Raasch, Helge Müller‐Fielitz and Eric Beitz. Their work appears in journals such as Journal of Medicinal Chemistry, ChemMedChem, Bioorganic & Medicinal Chemistry, ACS Pharmacology & Translational Science and Cell stem cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.